Hepcidin Testing Kit Diagnoses Iron Disorders

A medical diagnostic company released a kit that measures the hormone Hepcidin, which helps regulate the amount of iron in humans.

Unbalanced iron levels can lead to common medical conditions including anemia, chronic kidney disease, and iron overload diseases. The new enzyme-linked immunosorbant assay (ELISA) hepcidin kit was jointly developed by teams in the United States and Germany, under the strict standards of DRG International (Mountainside, NJ, USA)

The new DRG hepcidin 25 (C-terminal) ELISA kit will be available to medical professionals worldwide. It provides a simple, fast, and accurate method to test patient hepcidin levels. The measurement results will offer information to clinicians to help them diagnose and treat some of the most common iron-deficiency diseases worldwide.

"With many health problems related to Hepcidin, the research team at DRG recognized the need to invent a testing kit, and put it in the hands of health professionals across the globe as soon as possible," stated Dr. Cyril E. Geacintov, chairman of DRG International. "This kit provides accurate information, is user-friendly, and will help meet the rapidly growing worldwide demand for such a testing kit."

DRG International, Inc. is a leading specialty medical equipment and diagnostics manufacturer. The company provides a complete range of products and services to the diagnostics medical community.

Related Links:
DRG International